Admetsys
Admetsys is a biomedical technology company specializing in critical care automation. The company's flagship PrecisionOne system is the first fully automated glycemic control system and continuous blood diagnostics platform for hospital care. The company was founded to commercialize the next generation of medical automation technology: continuous real-time biosensing, robotics, artificial intelligence and learning algorithms, intelligent therapeutic delivery, and advanced data telemetry.
Admetsys
Admetsys provides an automated clinical robotic system for blood analysis and metabolic control, targeting critical care patients and hospitals.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Automated blood analysis systems
Metabolic control systems
Continuous blood diagnostics tools
AI-driven metabolic modeling software
Integration platform for biosensors and infusion pumps
Service Requirements
Technical implementation support for automated systems
Training for clinical staff on new robotic systems
Consulting on process improvement in critical care units
Expertise in integrating with existing hospital systems
Infrastructure Requirements
Extracorporeal blood biosensing devices
Automated infusion systems
Cloud infrastructure for data analysis and AI modeling
Security and compliance solutions for patient data
Talent Requirements
Engineers specializing in clinical robotics
AI and machine learning experts for metabolic modeling
Biomedical engineers for biosensor integration
Regulatory affairs specialists for FDA clearance
Sales and marketing professionals for market expansion
AI Insights
Growth Trajectory
Admetsys demonstrates strong growth potential through its FDA Breakthrough designation and CE Mark approval, indicating readiness for market expansion upon securing necessary clearances.
Market Opportunity
Admetsys has a significant market opportunity to transform critical care through high-precision automation, addressing the limitations of manual processes and clinical staffing shortages.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats